This round-up looks at the new developments in Japan's health foods and supplements industry, including Kirin's NPD using matured hop bitter acids and Ajinomoto's plans to seize business opportunities ahead of the upcoming Tokyo Olympics,...
In this round up, we look at some of the new developments that took place in APAC’s health and nutrition regulatory space, including the South Korean authorities’ clampdown on influencers ads that made false health claims.
Asian women prefer sports nutrition products that claim aesthetic benefits and weight loss more so than female consumers from the other parts of the world, according to exclusive new insights from Lumina Intelligence.
In this round-up of new developments happening in China’s health and nutrition supplement industry, we shed light on the upcoming consumption trends for this year, including the up-and-coming A2 milk market.
See December's 10 most read health and nutrition stories, including Nestlé Health Science China's new product innovation centre, FANCL launching its first cold care supplement, and new nutritional labelling requirements from Taiwan FDA.
China’s A2 milk sector is likely to see the rise of more products catered to different life stages and specific consumers groups, beyond just infant nutrition, as more domestic companies join in the competition.
In this round-up, we shine the spotlight on new product launches from big brand names such as Kirin, Ajinomoto and FANCL. We also find out why MLM brand LifeVantage and Australia’s Vitaco are expanding their presence in New Zealand and India respectively.
In this round up, we look at the ongoing trends in APAC nutrition and supplement market. In particular, more brands are harnessing the booming popularity of livestreaming to promote their products to Chinese consumers. We also find out from retailers,...
International ingredient firm Wacker says that the use of natural ingredients, such as curcumin and hydroxytyrosol in functional food is gaining steam in Asia, but there is a need to address issues such as low bioavailability.